ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BMK Benchmark Holdings Plc

44.75
-3.25 (-6.77%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Benchmark Holdings Plc LSE:BMK London Ordinary Share GB00BGHPT808 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.25 -6.77% 44.75 44.50 45.00 46.00 44.60 44.60 143,492 16:35:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 169.74M -23.15M -0.0313 -14.38 332.71M
Benchmark Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker BMK. The last closing price for Benchmark was 48p. Over the last year, Benchmark shares have traded in a share price range of 33.80p to 48.00p.

Benchmark currently has 739,352,390 shares in issue. The market capitalisation of Benchmark is £332.71 million. Benchmark has a price to earnings ratio (PE ratio) of -14.38.

Benchmark Share Discussion Threads

Showing 801 to 823 of 1100 messages
Chat Pages: 44  43  42  41  40  39  38  37  36  35  34  33  Older
DateSubjectAuthorDiscuss
22/10/2018
12:17
:O That's a big sell... Enjoy the rollercoaster!
btfd497
22/10/2018
11:33
6 million share trade. That's nearly 1.1% of the Company. I wonder what the story behind it is.
murdo mcsponge
13/10/2018
12:39
I agree with you - a very long term hold, but IMHO it's doing all the right things in a fast expanding industry and has a team that understands that industry.
murdo mcsponge
12/10/2018
18:22
Been holding these for almost a year now. I should have taken some profits when it rose to 80p but i got greedy... I still have faith in the company and am wait for their next trading update so the share price can rise again. I think this is a great long term share.
btfd497
03/10/2018
07:27
Purchase of Videntis. Good move IMHO.
murdo mcsponge
11/9/2018
23:16
Sea lice on salmon getting a lot of publicity recently with a feature even making it's way on to the One Show the other day. Benchmark's Clean Treat system could prove a very interesting and hopefully profitable development for the company. Worth watching the process

Dibbs

dibbs
17/8/2018
09:44
Jimarilo,you are totally wrong in believing that farmed salmon are full of chemicals and fat.farming of salmon has progressed significantly over the last few years and use of chemicals has largely disappeared.The use of cleaner fish ,balian wrasse and lumpfish(both now farmed rather than caught)has been very successful in reducing sea lice levels and fresh water treatments are now proving successful in both lice control and ensuring gill health.I have just returned from Norway.They produce 1.3m tonnes per annum and used I understand used only 278kg last year of antibiotics etc.
On the feeding side the industry is now far more dependant on grain based feed rather than fishmeal.
Overall salmon farming beats pork,beef etc handsdown as a way of producing protein.

mjcferguson
13/8/2018
03:58
I won't touch farmed salmon, full of fat and chemicals

Not to mention the effect on wild salmon and sea trout, this is not a sustainable business in it's current form

jimarilo
13/8/2018
02:47
Should be captivity, using a very small keyboard and I've been awake a long time.
petes5
13/8/2018
02:46
Not holding these at the moment but just read an article about sea wraas. These are used on salmon farms for keeping lice under control but until now have had to be taken from the wild and populations are dropping. They are now able to breed these in cativity. This could be a major game changer in keeping lice under control but state that other methods will still be utilised.
petes5
06/7/2018
10:00
If you want to see the CEO and CFO run through the recent results and talk about company prospects , 30 min video interview here:
edmonda
26/6/2018
17:20
Updated research just published on Benchmark's strategic positioning and new fair value calculation. Freely available at:
edmonda
22/6/2018
07:13
Follow directors buy
nw99
12/6/2018
17:21
It's all in the RNS... just click on the link under the header above for 8th June Trading Update

Don't just read a news 'story'

e.g.

Placing of New Ordinary Shares

The JV is being funded by a placing of 34,545,455 new ordinary shares (the "Placing Shares") at a price of 55 pence per share (the "Placing Price") to raise £19m before expenses (the " Placing ").

...and there's *full* details of all EBITDA calcs for the next 3 years...

The deal looks good to me, and the offering has been well received.

tinman
12/6/2018
17:10
after last week's trading update, JV in Chile and associated placing: new research note out ahead of results 19 June. Freely available here:

edmonda
08/6/2018
14:56
Oh, & an XR or OO for PIs?
Nah, they don't even make it clear at what price these new shares are being "valued".
I'm told it is 55p....

"Placing to raise GBP19.0 million (before expenses)" - How many shares?
"Acquisition of 49% interest " - minority holding....

This really puzzles me : -
"adjusted EBITDA contribution:
-- in the four months to 30 September 2018 of GBP1.81m" (= GBP 5.4m per annum)
"-- for the first full year to 30 September 2019 of approximately GBP2.4m" (so why less than half of above?)
"-- of GBP4.1m at full capacity" (getting there.......!)

I used to have some of these.
In no hurry to buy back in.

napoleon 14th
08/6/2018
14:52
Now we know why the fall in share price
Funny how the market knew, innit?
I mean, far be it for me to suggest........

napoleon 14th
22/5/2018
21:09
He also knows we have the same golf handicap
lucicavi
22/5/2018
21:03
Johnson 09 knows nothing
nw99
21/5/2018
13:21
61-62 nice and tight. Shall i buy another 20 or shall i let johnson09 have them
lucicavi
21/5/2018
12:45
What’s it all about?
Benchmark is a highly interesting player in the booming Aquaculture
industry, which ticks many ESG boxes. Through M&A, a unique platform has
been built with significant exposure to the high value added, early life stages
of fish. The portfolio includes a range of seed, feed and healthcare products,
with prospects of double-digit sales growth on >20% EBITDA margins for
2016-18E. That said, earnings visibility is limited and we fear that the capital
return profile will remain unattractive for several years. We would welcome
a temporary step back from M&A and a focus on achieving revenue
synergies. The shares trade at an adjusted 2017 EBITDA multiple of 12x, and
our DCF analysis comes out at 95p. Backed by our SOP fair value of 73p per
share, we initiate coverage with a Buy rating.

rubberbullets
21/5/2018
12:32
NEW recent high now,.
rubberbullets
21/5/2018
11:12
TAKE OFF TIME
rubberbullets
Chat Pages: 44  43  42  41  40  39  38  37  36  35  34  33  Older

Your Recent History

Delayed Upgrade Clock